Enabling Technologies for Personalized and Precision MedicineDean Ho, Ali Zarrinpar, Bruce D. Gelb et al.|Trends in biotechnology|2020Cited by 483
Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IEmil Kakkis, Merry Passage, Michael F. McEntee et al.|Molecular Genetics and Metabolism|2004Cited by 168
Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transportXu‐Qiao Chen, William C. Mobley|Alzheimer s Research & Therapy|2021Cited by 18
Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of<scp><i>APP</i></scp>Dose and Preclinical Studies of a γ‐Secretase ModulatorXu‐Qiao Chen, William C. Mobley|Annals of Neurology|2023Cited by 12
<scp>γ‐Secretase</scp> Modulator <scp>BPN15606</scp> Reduced Aβ42 and Aβ40 and Countered Alzheimer‐Related Pathologies in a Mouse Model of Down SyndromeXu‐Qiao Chen, William C. Mobley|Annals of Neurology|2024Cited by 12